US Stock MarketDetailed Quotes
SGMO Sangamo Therapeutics
- 2.802
- -0.009-0.30%
Trading Nov 8 10:19 ET
583.33MMarket Cap-2030P/E (TTM)
2.990High2.680Low3.68MVolume2.920Open2.810Pre Close10.36MTurnover1.94%Turnover RatioLossP/E (Static)208.22MShares2.99052wk High24.57P/B531.13MFloat Cap0.29152wk Low--Dividend TTM189.59MShs Float51.375Historical High--Div YieldTTM11.03%Amplitude0.291Historical Low2.811Avg Price1Lot Size
About Sangamo Therapeutics Company
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
Company Profile
SymbolSGMO
Company NameSangamo Therapeutics
Listing DateApr 6, 2000
Issue Price15.00
Founded1995
CEODr. Alexander Donald Macrae, M.B.,PhD
MarketNASDAQ
Employees405
Fiscal Year Ends12-31
Address501 Canal Boulevard
CityRichmond
ProvinceCalifornia
CountryUnited States of America
Zip Code94084
Phone1-510-970-6000
Websitehttp://www.sangamo.com
Company Executives
-
Name
- Position
- Salary
-
Dr. Alexander Donald Macrae, M.B.,PhD
- Director, President and Chief Executive Officer
- 2.39M
-
Nathalie Dubois-Stringfellow, PhD
- Senior Vice President and Chief Development Officer
- 1.03M
-
Prathyusha Duraibabu
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- 1.06M
-
Amy Pooler, PhD
- Vice President and Head of Research
- --
-
Scott B. Willoughby
- Senior Vice President, General Counsel and Corporate Secretary
- --
-
James R. Meyers
- Independent Director
- 78.66K
-
Courtney Beers
- Independent Director
- 73.24K
-
Margaret A. Horn, J.D.
- Independent Director
- 71.25K
-
Dr. Kenneth J. Hillan, Ch.B.,M.B.
- Independent Director
- 71.16K
-
Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
- Independent Director
- 76.78K
-
Robert F. Carey
- Independent Director
- 80.53K
-
Dr. John H. Markels, PhD
- Independent Director
- 76.78K
-
H. Stewart Parker
- Chairwoman of the Board
- 99.28K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
